ClinConnect ClinConnect Logo
Search / Trial NCT05307666

MinMed: Do Older Adults do Better With Less Medication

Launched by UNIVERSITY OF ALBERTA · Mar 23, 2022

Trial Information

Current as of June 29, 2025

Enrolling by invitation

Keywords

Polypharmacy Deprescribing Minimum Effective Dose Geriatric Prescribing

ClinConnect Summary

PURPOSE

To organize primary care providers, and their older patients with polypharmacy, in a way that permits them to collaboratively determine the lowest effective dose of all amenable medications. And, in so doing, to provide randomized controlled trial evidence as to whether minimizing medication doses improves health outcomes in this population.

HYPOTHESIS

1. Primary care providers can easily reduce medication doses in their own patients when organized appropriately to do so.
2. Determining and utilizing the minimum effective dose of all medications will prolong independence, reduce ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Attached to participating primary care providers
  • 2. Community dwelling (i.e. not living in a nursing home or supportive living facility)
  • 3. ≥80 years of age
  • 4. Using ≥6 long-term oral medications (defined as orally administered medications dispensed ≥2 times in the preceding 200 days)
  • Exclusion Criteria:
  • None

About University Of Alberta

The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.

Locations

Edmonton, Alberta, Canada

Patients applied

0 patients applied

Trial Officials

Scott Garrison, MD, PhD

Principal Investigator

University of Alberta

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials